Skip to main content
RDHL
NASDAQ Life Sciences

RedHill Biopharma Secures Up To $19.4M Private Placement at Deep Discount, Massive Dilution Expected

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.78
Mkt Cap
$4.075M
52W Low
$0.71
52W High
$3.31
52W Position info
9.8% above low
Off High info
76% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

RDHL is trading near its 52-week low of $0.71 (9.8% above the low) on light trading volume (0.3× avg).

Summary

RedHill Biopharma announced a private placement to raise up to $19.4 million, including $6 million upfront, at a significant discount to its current stock price, which will result in massive dilution for existing shareholders but provides crucial capital for the financially distressed company.


Key Events · Financing and Capital Events · RDHL

  • Private Placement Announced

    RedHill Biopharma entered into a definitive agreement for a private placement to raise up to $19.4 million.

  • Upfront Capital Infusion

    The company expects to receive approximately $6 million in gross proceeds from the initial sale of 8,571,429 American Depositary Shares (ADSs) and accompanying warrants.

  • Significant Potential Dilution

    An additional $13.4 million could be raised if all Series A-1 and Series A-2 warrants are fully exercised, leading to a total potential raise of $19.4 million. The upfront raise alone represents 147% of the current market cap, with the total potential raise being 475%.

  • Discounted Pricing

    The combined purchase price for the ADSs and warrants is $0.70 per ADS, which is a discount to the current stock price of $0.7799.


Analysis · RDHL · Life Sciences

RedHill Biopharma, a company facing a "going concern" warning and Nasdaq delisting, has secured a private placement for up to $19.4 million. This includes $6 million upfront from the sale of ADSs and warrants, with an additional $13.4 million potential from warrant exercises. The offering price of $0.70 per ADS and accompanying warrants is at a discount to the current market price of $0.7799. While this capital infusion is critical for the company's immediate survival and operations, it represents extreme dilution for existing shareholders, with the upfront raise alone being 147% of the current market cap and the total potential raise being 475%.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 51.2% of the 201 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RDHL was trading at $0.78 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.1M. The 52-week trading range was $0.71 to $3.31. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RDHL - Latest Insights

RDHL
Oct 07, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4981
Real-time Price: $0.4252 info
Change: -$0.0729 (-15%) info
Market Cap: $3.751M info
RDHL
Sep 30, 2026, 4:11 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4797
Real-time Price: $0.4252 info
Change: -$0.0545 (-11%) info
Market Cap: $3.751M info
RDHL
Sep 01, 2026, 7:10 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.9195
Real-time Price: $0.4252 info
Change: -$0.4943 (-54%) info
Market Cap: $3.751M info
RDHL
Sep 01, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.9016
Real-time Price: $0.4252 info
Change: -$0.4764 (-53%) info
Market Cap: $3.751M info
RDHL
Aug 31, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $0.6303
Real-time Price: $0.4252 info
Change: -$0.2051 (-33%) info
Market Cap: $3.751M info